Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 31 (Search time: 0.003 seconds).
Item hits:
Issue DateTitleAuthor(s)
1-Jan-2015No relationship between drug transporter genetic variants and tenofovir plasma concentrations or changes in glomerular filtration rate in HIV-infected adultsSirirungsi W.; Urien S.; Urien S.; Urien S.; Harrison L.; Harrison L.; Kamkon J.; Kamkon J.; Tawon Y.; Tawon Y.; Luekamlung N.; Thongpaen S.; Nilmanat A.; Jourdain G.; Jourdain G.; Jourdain G.; Lallemant M.; Lallemant M.; Lallemant M.; Le Coeur S.; Le Coeur S.; Le Coeur S.; Ngo-Giang-Huong N.; Ngo-Giang-Huong N.; Ngo-Giang-Huong N.; Owen A.; Cressey T.; Cressey T.; Cressey T.
2010Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failureJourdain G.; Wagner T.A.; Ngo-Giang-Huong N.; Sirirungsi W.; Klinbuayaem V.; Fregonese F.; Nantasen I.; Techapornroong M.; Halue G.; Nilmanat A.; Wittayapraparat P.; Chalermpolprapa V.; Pathipvanich P.; Yuthavisuthi P.; Frenkel L.M.; Lallemant M.
2010Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: Comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assayWagner T.A.; Kress C.M.; Beck I.; Techapornroong M.; Wittayapraparat P.; Tansuphasawasdikul S.; Jourdain G.; Ngo-Giang-Huong N.; Lallemant M.; Frenkel L.M.
2010Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapineLallemant M.; Ngo-Giang-Huong N.; Jourdain G.; Traisaithit P.; Cressey T.R.; Collins I.J.; Jarupanich T.; Sukhumanant T.; Achalapong J.; Sabsanong P.; Chotivanich N.; Winiyakul N.; Ariyadej S.; Kanjanasing A.; Ratanakosol J.; Hemvuttiphan J.; Kengsakul K.; Wannapira W.; Sittipiyasakul V.; Pornkitprasarn W.; Liampongsabuddhi P.; Mcintosh K.; Van Dyke R.B.; Frenkel L.M.; Koetsawang S.; Le Coeur S.; Kanchana S.
2014Estimating the timing of mother-to-child transmission of the human immunodeficiency virus type 1 using a viral molecular evolution modelChaillon A.; Samleerat T.; Zoveda F.; Ballesteros S.; Moreau A.; Ngo-Giang-Huong N.; Jourdain G.; Gianella S.; Lallemant M.; Depaulis F.; Barin F.
2014Cost-effectiveness of early infant HIV diagnosis of HIV-exposed infants and immediate antiretroviral therapy in HIV-infected children under 24 months in ThailandCollins I.J.; Cairns J.; Ngo-Giang-Huong N.; Sirirungsi W.; Leechanachai P.; Coeur S.L.; Samleerat T.; Kamonpakorn N.; Mekmullica J.; Jourdain G.; Lallemant M.
2007Immunochromatographic strip test for rapid detection of nevirapine in plasma samples from human immunodeficiency virus-infected patientsCressey T.R.; Nangola S.; Tawon Y.; Pattarawarapan M.; Lallemant M.; Tayapiwatana C.
2010Pharmacogenetics and the prevention of mother-to-child transmission of HIVCressey T.R.; Lallemant M.
2011Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected thai patients receiving indinavir boosted with ritonavirCressey T.R.; Urien S.; Hirt D.; Halue G.; Techapornroong M.; Bowonwatanuwong C.; Leenasirimakul P.; Treluyer J.-M.; Jourdain G.; Lallemant M.
2011Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: A Bayesian analysisNgo-Giang-Huong N.; Jourdain G.; Amzal B.; Sang-a-gad P.; Lertkoonalak R.; Eiamsirikit N.; Tansuphasawasdikul S.; Buranawanitchakorn Y.; Yutthakasemsunt N.; Mekviwattanawong S.; McIntosh K.; Lallemant M.